[HTML] springer.com

[HTML][HTML] Impact on the incremental cost-effectiveness ratio of using alternatives to EQ-5D in a Markov model for multiple sclerosis

M Versteegh - Pharmacoeconomics, 2016 - Springer
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …
被引用次数：16 相关文章

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - PharmacoEconomics, 2016 - pubmed.ncbi.nlm.nih.gov
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …
[HTML] nih.gov

[HTML][HTML] Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - Pharmacoeconomics, 2016 - ncbi.nlm.nih.gov
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - PharmacoEconomics, 2016 - repub.eur.nl
Objectives: This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …
[PDF] researchgate.net

[PDF][PDF] Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - researchgate.net
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …
[PDF] cyberleninka.org

[PDF][PDF] Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - cyberleninka.org
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - PharmacoEconomics, 2016 - infona.pl
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - PharmacoEconomics, 2016 - ideas.repec.org
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.

M Versteegh - Pharmacoeconomics, 2016 - europepmc.org
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

M Versteegh - PharmacoEconomics, 2016 - econpapers.repec.org
Objectives This study responds to a request in the National Institute for Health and Care
Excellence (NICE) guidance to assess the impact of using alternative sources of utility …